IL155680A0 - Method for the production of 4-alph-(17alpha substituted 3-oxoestra-4,9-dien-11-yl) enzaldehyde-(1e or 1z)-oximes - Google Patents

Method for the production of 4-alph-(17alpha substituted 3-oxoestra-4,9-dien-11-yl) enzaldehyde-(1e or 1z)-oximes

Info

Publication number
IL155680A0
IL155680A0 IL15568001A IL15568001A IL155680A0 IL 155680 A0 IL155680 A0 IL 155680A0 IL 15568001 A IL15568001 A IL 15568001A IL 15568001 A IL15568001 A IL 15568001A IL 155680 A0 IL155680 A0 IL 155680A0
Authority
IL
Israel
Prior art keywords
sub
oxoestra
17alpha
dien
oximes
Prior art date
Application number
IL15568001A
Other languages
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL155680A0 publication Critical patent/IL155680A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Studio Devices (AREA)
IL15568001A 2000-11-10 2001-11-09 Method for the production of 4-alph-(17alpha substituted 3-oxoestra-4,9-dien-11-yl) enzaldehyde-(1e or 1z)-oximes IL155680A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10056676A DE10056676A1 (de) 2000-11-10 2000-11-10 Verfahren zur Herstellung von 4-/17alpha-substituierten-3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1E oder 1Z)-oximen
PCT/DE2001/004218 WO2002038582A2 (de) 2000-11-10 2001-11-09 Verfahren zur herstellung von 4-(17alpha-(substituierten-methyl)-3-oxoestra-4,9 dien-11-yl)benzaldehyd-(1e oder 1z)-oximen

Publications (1)

Publication Number Publication Date
IL155680A0 true IL155680A0 (en) 2003-11-23

Family

ID=7663441

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15568001A IL155680A0 (en) 2000-11-10 2001-11-09 Method for the production of 4-alph-(17alpha substituted 3-oxoestra-4,9-dien-11-yl) enzaldehyde-(1e or 1z)-oximes
IL155680A IL155680A (en) 2000-11-10 2003-04-30 Method to generate 4- (17 alpha-converted 3 - oxoester - 4,9 - diane - 11 - il) benzaldehyde - (1 E or 1Z) - oximes

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL155680A IL155680A (en) 2000-11-10 2003-04-30 Method to generate 4- (17 alpha-converted 3 - oxoester - 4,9 - diane - 11 - il) benzaldehyde - (1 E or 1Z) - oximes

Country Status (25)

Country Link
US (1) US7214808B2 (https=)
EP (1) EP1339734B1 (https=)
JP (1) JP4263478B2 (https=)
KR (1) KR100836323B1 (https=)
CN (1) CN100368427C (https=)
AT (1) ATE337328T1 (https=)
AU (2) AU2002216911B2 (https=)
BG (1) BG107886A (https=)
BR (1) BR0115249A (https=)
CA (1) CA2427632C (https=)
CZ (1) CZ301425B6 (https=)
DE (2) DE10056676A1 (https=)
EA (1) EA005530B1 (https=)
EE (1) EE200300222A (https=)
HR (1) HRP20030458A2 (https=)
HU (1) HUP0301765A2 (https=)
IL (2) IL155680A0 (https=)
MX (1) MXPA03004109A (https=)
NO (1) NO20032080D0 (https=)
NZ (1) NZ525962A (https=)
PL (1) PL205091B1 (https=)
SK (1) SK286601B6 (https=)
WO (1) WO2002038582A2 (https=)
YU (1) YU34303A (https=)
ZA (1) ZA200304480B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006018888A1 (de) * 2006-04-18 2007-10-25 Bayer Schering Pharma Ag Verfahren zur Herstellung von 4-[17beta-Methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyd-(E)-oxims (Asoprisnil)
JP4843372B2 (ja) * 2006-05-09 2011-12-21 株式会社リコー 画像処理装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5576310A (en) * 1994-09-20 1996-11-19 Jenapharm Gmbh 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds

Also Published As

Publication number Publication date
BR0115249A (pt) 2003-08-12
KR100836323B1 (ko) 2008-06-09
AU2002216911C1 (en) 2002-05-21
NO20032080L (no) 2003-05-09
US7214808B2 (en) 2007-05-08
WO2002038582A3 (de) 2002-09-12
WO2002038582A2 (de) 2002-05-16
DE50110829D1 (de) 2006-10-05
US20040053905A1 (en) 2004-03-18
CA2427632C (en) 2010-01-26
AU1691102A (en) 2002-05-21
AU2002216911B2 (en) 2007-06-14
EA200300506A1 (ru) 2003-12-25
IL155680A (en) 2009-06-15
ZA200304480B (en) 2004-08-24
JP2004513179A (ja) 2004-04-30
CZ301425B6 (cs) 2010-02-24
NO20032080D0 (no) 2003-05-09
CZ20031282A3 (cs) 2003-08-13
PL205091B1 (pl) 2010-03-31
PL361399A1 (en) 2004-10-04
ATE337328T1 (de) 2006-09-15
EP1339734B1 (de) 2006-08-23
JP4263478B2 (ja) 2009-05-13
CN1474829A (zh) 2004-02-11
CA2427632A1 (en) 2003-05-01
HUP0301765A2 (hu) 2003-09-29
DE10056676A1 (de) 2002-05-16
EE200300222A (et) 2003-08-15
SK5512003A3 (en) 2003-10-07
SK286601B6 (sk) 2009-02-05
YU34303A (sh) 2006-08-17
HRP20030458A2 (en) 2005-04-30
CN100368427C (zh) 2008-02-13
KR20030081330A (ko) 2003-10-17
NZ525962A (en) 2005-02-25
BG107886A (bg) 2004-02-27
HK1063187A1 (en) 2004-12-17
EA005530B1 (ru) 2005-04-28
EP1339734A2 (de) 2003-09-03
MXPA03004109A (es) 2004-07-08

Similar Documents

Publication Publication Date Title
BG101833A (bg) Гуаниново производно
AU2001226100A1 (en) Method for high yield reticle formation
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
WO2002020501A3 (en) Polyarylcarboxamides useful as lipid lowering agents
NO932870D0 (no) Ny fremgangsmaate for fremstilling av 9-amino-6-demetyl-6-deoksyetracykliner
GR1004074B (el) Μεθοδος παρασκευης της σιταλοπραμης.
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
PT1101755E (pt) Derivados do acido antranilico
DE60306667D1 (de) Cefdinir salze als zwischenprodukte
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
HU9904634D0 (en) New thiaazolidine-derivatives
EA200200101A1 (ru) Получение замещенных пиперидин-4-онов
AU1691102A (en) Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e or 1z)-oximes
WO2002024690A8 (en) Efficient process for the preparation of a factor xa inhibitor
AU2001293856A1 (en) A process for the preparation of pantoprazole and intermediates therefor
IL156768A0 (en) Process for preparing (+/-) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
FR2822842B1 (fr) Procede de preparation d'un neo-tissu cartilagineux
PT1581504E (pt) Processo de preparação de derivados de imidazole substituídos e intermediários utilizados no processo
DK1219625T3 (da) Hidtil ukendte substituerede 2-(6-benzyl-5-oxo-3-phenyl-(S3,7S,7AR)-perhydroimidazol-(1,5-C)(1,3) thiazol-7YL)forbindelser
NO20032079L (no) Fremgangsmåte for fremstilling av 4-(17<alfa>-metyl- substituerte-3-oksoöstra-4,9-dien-11<beta>-yl)benzaldehyd-(1E eller 1Z)-oksimer
WO2000018777A3 (en) Method for synthesizing c-glycosides of ulosonic acids
AU2003250932A1 (en) Method for producing macrocyclic ketones by means of dieckmann condensation in the gas phase
AU2002216911A1 (en) Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1E or 1Z)-oximes
EP1254893A3 (en) 2-halo-1-cycloalkenecarboxamides and their preparation
WO2002069909A3 (en) Synthesis of ketosulfone esters